Liver X receptor agonist T0901317 induced liver perturbation in zebrafish: Histological, gene set enrichment and expression analyses

Biochimica et Biophysica Acta - General Subjects

Volumn 1820, Issue 1, 2012, Pages 33-43

  Sukardi, Hendrian ^a   Zhang, Xiaoyan ^a   Lui, Eei Yin ^a   Ung, Choong Yong ^a   Mathavan, Sinnakaruppan ^b   Gong, Zhiyuan ^a   Lam, Siew Hong ^a  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

Liver; Liver X receptor; T0901317; Toxicogenomics; Transcriptome; Zebrafish

Indexed keywords

GLYCOGEN; LIVER X RECEPTOR; LIVER X RECEPTOR AGONIST; N (2,2,2 TRIFLUOROETHYL) N [4 [2,2,2 TRIFLUORO 1 HYDROXY 1 (TRIFLUOROMETHOXY)ETHYL]PHENYL]BENZENESULFONAMIDE; PROTEASOME;

ANTIATHEROGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTITHROMBOGENIC ACTIVITY; ARTICLE; ATHEROGENESIS; BLOOD CLOTTING; CARBOHYDRATE METABOLISM; CELL ADHESION; CELL DEATH; CELL SWELLING; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE REPRESSION; HISTOPATHOLOGY; LIPID METABOLISM; MALE; MICROARRAY ANALYSIS; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOXICOGENETICS; UPREGULATION; ZEBRA FISH;

ANIMALS; CARBOHYDRATE METABOLISM; CELL ADHESION; DOWN-REGULATION; EXTRACELLULAR MATRIX; HYDROCARBONS, FLUORINATED; LIPID METABOLISM; LIVER; MALE; ORPHAN NUCLEAR RECEPTORS; SIGNAL TRANSDUCTION; SULFONAMIDES; TOXICITY TESTS; ZEBRAFISH;

DANIO RERIO; MAMMALIA; VERTEBRATA;

EID: 81155144526     PISSN: 03044165     EISSN: 18728006     Source Type: Journal    
DOI: 10.1016/j.bbagen.2011.10.009     Document Type: Article

References (46)

1. J.L. Collins, A.M. Fivush, M.A. Watson, C.M. Galardi, M.C. Lewis, L.B. Moore, D.J. Parks, J.G. Wilson, T.K. Tippin, J.G. Binz, K.D. Plunket, D.G. Morgan, E.J. Beaudet, K.D. Whitney, S.A. Kliewer, and T.M. Willson Identification of a nonsteroidal liver X receptor agonist through parallel array synthesis of tertiary amines J. Med. Chem. 45 2002 1963 1966 (Pubitemid 34477709)
2. D.W. Russell Nuclear orphan receptors control cholesterol catabolism Cell 97 1999 539 542 (Pubitemid 29256955)
3. J.J. Repa, S.D. Turley, J.A. Lobaccaro, J. Medina, L. Li, K. Lustig, B. Shan, R.A. Heyman, J.M. Dietschy, and D.J. Mangelsdorf Regulation of absorption and ABC1-mediated efflux of cholesterol by RXR heterodimers Science 289 2000 1524 1529
4. A. Archer, G. Lauter, G. Hauptmann, A. Mode, and J.A. Gustafsson Transcriptional activity and developmental expression of liver X receptor (lxr) in zebrafish Dev. Dyn. 237 2008 1090 1098 (Pubitemid 351542305)
5. J.M. Maglich, J.A. Caravella, M.H. Lambert, T.M. Willson, J.T. Moore, and L. Ramamurthy The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily Nucleic Acids Res. 31 2003 4051 4058 (Pubitemid 37442285)
6. B.A. Laffitte, L.C. Chao, J. Li, R. Walczak, S. Hummasti, S.B. Joseph, A. Castrillo, D.C. Wilpitz, D.J. Mangelsdorf, J.L. Collins, E. Saez, and P. Tontonoz Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue Proc. Natl. Acad. Sci. U. S. A. 100 2003 5419 5424 (Pubitemid 36542720)
7. M. Baranowski Biological role of liver X receptors J. Physiol. Pharmacol. 59 Suppl 7 2008 31 55
8. S.B. Joseph, E. McKilligin, L. Pei, M.A. Watson, A.R. Collins, B.A. Laffitte, M. Chen, G. Noh, J. Goodman, G.N. Hagger, J. Tran, T.K. Tippin, X. Wang, A.J. Lusis, W.A. Hsueh, R.E. Law, J.L. Collins, T.M. Willson, and P. Tontonoz Synthetic LXR ligand inhibits the development of atherosclerosis in mice Proc. Natl. Acad. Sci. U. S. A. 99 2002 7604 7609 (Pubitemid 34568738)
9. N. Zelcer, and P. Tontonoz Liver X receptors as integrators of metabolic and inflammatory signaling J. Clin. Invest. 116 2006 607 614 (Pubitemid 43326865)
10. G. Cao, Y. Liang, C.L. Broderick, B.A. Oldham, T.P. Beyer, R.J. Schmidt, Y. Zhang, K.R. Stayrook, C. Suen, K.A. Otto, A.R. Miller, J. Dai, P. Foxworthy, H. Gao, T.P. Ryan, X.C. Jiang, T.P. Burris, P.I. Eacho, and G.J. Etgen Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis J. Biol. Chem. 278 2003 1131 1136 (Pubitemid 36790794)
11. S.R. Chintalacharuvu, G.E. Sandusky, T.P. Burris, G.C. Burmer, and S. Nagpal Liver X receptor is a therapeutic target in collagen-induced arthritis Arthritis Rheum. 56 2007 1365 1367 (Pubitemid 46608662)
12. X. Li, V. Yeh, and V. Molteni Liver X receptor modulators: a review of recently patented compounds (2007-2009) Expert Opin. Ther. Pat. 20 2010 535 562
13. J.J. Repa, and D.J. Mangelsdorf The liver X receptor gene team: potential new players in atherosclerosis Nat. Med. 8 2002 1243 1248 (Pubitemid 35373555)
14. J.W. Chisholm, J. Hong, S.A. Mills, and R.M. Lawn The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse J. Lipid Res. 44 2003 2039 2048 (Pubitemid 37509619)
15. A. Schlegel, and D.Y. Stainier Lessons from "lower" organisms: what worms, flies, and zebrafish can teach us about human energy metabolism PLoS Genet. 3 2007 e199
16. C. Sullivan, and C.H. Kim Zebrafish as a model for infectious disease and immune function Fish Shellfish Immunol. 25 2008 341 350
17. P. Jagadeeswaran Zebrafish: a tool to study hemostasis and thrombosis Curr. Opin. Hematol. 12 2005 149 152 (Pubitemid 40315700)
18. H.M. Stern, and L.I. Zon Cancer genetics and drug discovery in the zebrafish Nat. Rev. Cancer 3 2003 533 539 (Pubitemid 37328841)
19. H. Sukardi, H.T. Chng, E.C. Chan, Z. Gong, and S.H. Lam Zebrafish for drug toxicity screening: bridging the in vitro cell-based models and in vivo mammalian models Expert Opin. Drug Metab. Toxicol. 7 2011 579 589
20. S.H. Lam, S. Mathavan, Y. Tong, H. Li, R.K. Karuturi, Y. Wu, V.B. Vega, E.T. Liu, and Z. Gong Zebrafish whole-adult-organism chemogenomics for large-scale predictive and discovery chemical biology PLoS Genet. 4 2008 e1000121
21. S.H. Lam, R. Krishna Murthy Karuturi, and Z. Gong Zebrafish spotted-microarray for genome-wide expression profiling experiments: data acquisition and analysis Methods Mol. Biol. 546 2009 197 226
22. S.H. Lam, S. Mathavan, and Z. Gong Zebrafish spotted-microarray for genome-wide expression profiling experiments. Part I: array printing and hybridization Methods Mol. Biol. 546 2009 175 195
23. A. Subramanian, P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles Proc. Natl. Acad. Sci. U. S. A. 102 2005 15545 15550 (Pubitemid 41528093)
24. Z.D. Goodman, and H.R. Makhlouf Hepatic Histopathology 2007 Lippincott Williams & Wilkins 245-311 pp.
25. E. Camerer, A.B. Kolsto, and H. Prydz Cell biology of tissue factor, the principal initiator of blood coagulation Thromb. Res. 81 1996 1 41 (Pubitemid 26027721)
26. H. Scholz, T. Lund, M.K. Dahle, J.L. Collins, O. Korsgren, J.E. Wang, and A. Foss The synthetic liver X receptor agonist GW3965 reduces tissue factor production and inflammatory responses in human islets in vitro Diabetologia 52 2009 1352 1362
27. N. Terasaka, A. Hiroshima, A. Ariga, S. Honzumi, T. Koieyama, T. Inaba, and T. Fujiwara Liver X receptor agonists inhibit tissue factor expression in macrophages FEBS J. 272 2005 1546 1556 (Pubitemid 40444942)
28. A.J. Lusis Atherosclerosis Nature 407 2000 233 241
29. F. Niculescu, and H. Rus Complement activation and atherosclerosis Mol. Immunol. 36 1999 949 955 (Pubitemid 30100847)
30. M. Okroj, D. Heinegard, R. Holmdahl, and A.M. Blom Rheumatoid arthritis and the complement system Ann. Med. 39 2007 517 530 (Pubitemid 350035568)
31. L. Verschuren, J. de Vries-van, S. der Weij, R. Zadelaar, and T. Kooistra Kleemann LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in apoE*3Leiden mice: time course and mechanisms J. Lipid. Res. 50 2009 301 311
32. A.H. Baker, D.R. Edwards, and G. Murphy Metalloproteinase inhibitors: biological actions and therapeutic opportunities J. Cell Sci. 115 2002 3719 3727 (Pubitemid 35203598)
33. M.F. Prescott, W.K. Sawyer, J. Von Linden-Reed, M. Jeune, M. Chou, S.L. Caplan, and A.Y. Jeng Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury Ann. N. Y. Acad. Sci. 878 1999 179 190 (Pubitemid 29353569)
34. Y. Wei, R.S. Rector, J.P. Thyfault, and J.A. Ibdah Nonalcoholic fatty liver disease and mitochondrial dysfunction World J. Gastroenterol. 14 2008 193 199 (Pubitemid 351314298)
35. S.W. French, and F. Bardag-Gorce Ubiquitin-Proteasome Pathway in the Pathogenesis of Liver Disease 2005 Springer Verlag Berlin
36. S.S. Choe, A.H. Choi, J.W. Lee, K.H. Kim, J.J. Chung, J. Park, K.M. Lee, K.G. Park, I.K. Lee, and J.B. Kim Chronic activation of liver X receptor induces beta-cell apoptosis through hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic beta-cells Diabetes 56 2007 1534 1543 (Pubitemid 46842606)
37. Z.X. Meng, J. Nie, J.J. Ling, J.X. Sun, Y.X. Zhu, L. Gao, J.H. Lv, D.Y. Zhu, Y.J. Sun, and X. Han Activation of liver X receptors inhibits pancreatic islet beta cell proliferation through cell cycle arrest Diabetologia 52 2009 125 135
38. J.J. Rough, M.A. Monroy, S. Yerrum, and J.M. Daly Anti-proliferative effect of LXR agonist T0901317 in ovarian carcinoma cells J. Ovarian Res. 3 2010 13
39. A.J. Pommier, G. Alves, E. Viennois, S. Bernard, Y. Communal, B. Sion, G. Marceau, C. Damon, K. Mouzat, F. Caira, S. Baron, and J.M. Lobaccaro Liver X Receptor activation downregulates AKT survival signaling in lipid rafts and induces apoptosis of prostate cancer cells Oncogene 29 2010 2712 2723
40. A.E. Feldstein, A. Canbay, P. Angulo, M. Taniai, L.J. Burgart, K.D. Lindor, and G.J. Gores Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis Gastroenterology 125 2003 437 443 (Pubitemid 36929425)
41. P.S. Ribeiro, H. Cortez-Pinto, S. Sola, R.E. Castro, R.M. Ramalho, A. Baptista, M.C. Moura, M.E. Camilo, and C.M. Rodrigues Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients Am. J. Gastroenterol. 99 2004 1708 1717 (Pubitemid 39237497)
42. B.A. Laffitte, S.B. Joseph, R. Walczak, L. Pei, D.C. Wilpitz, J.L. Collins, and P. Tontonoz Autoregulation of the human liver X receptor alpha promoter Mol. Cell. Biol. 21 2001 7558 7568 (Pubitemid 32988767)
43. J.C. Hutton, and R.M. O'Brien Glucose-6-phosphatase catalytic subunit gene family J. Biol. Chem. 284 2009 29241 29245
44. F. Blaschke, Y. Takata, E. Caglayan, A. Collins, P. Tontonoz, W.A. Hsueh, and R.K. Tangirala A nuclear receptor corepressor-dependent pathway mediates suppression of cytokine-induced C-reactive protein gene expression by liver X receptor Circ. Res. 99 2006 e88 e99
45. S. Ghisletti, W. Huang, K. Jepsen, C. Benner, G. Hardiman, M.G. Rosenfeld, and C.K. Glass Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways Genes Dev. 23 2009 681 693
46. H. Wang, Y. Zhang, E. Yehuda-Shnaidman, A.V. Medvedev, N. Kumar, K.W. Daniel, J. Robidoux, M.P. Czech, D.J. Mangelsdorf, and S. Collins Liver X receptor alpha is a transcriptional repressor of the uncoupling protein 1 gene and the brown fat phenotype Mol. Cell. Biol. 28 2008 2187 2200 (Pubitemid 351429966)